NFE2L2 and amyotrophic lateral sclerosis: Furthermore, the relevance of the NRF2 pathway in ALS pathology is also reinforced by the fact that one haplotype in NFE2L2, which includes three functional promoter SNPs associated with increased protein expression of NRF2, was associated with delayed disease onset of 4 years per allele [40].